ArticleKidney diseases (Basel, Switzerland)
Predicting Adverse Outcomes in Kidney Transplant Recipients Using an Interpretable Model Based on Shear-Wave Elastography.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kidney Elastography in Adult Nephrology: A Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
- A bibliometric analysis of ultrasound-based evaluation in renal transplantation.Translational andrology and urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Shear-wave elastography (SWE) is a promising noninvasive technique for measuring renal fibrosis after transplantation. This study aimed to develop an interpretable model to predict allograft deterioration in kidney transplant recipients and evaluate the predictive ability of SWE features. Methods: In this prospective cohort study, we performed SWE examinations on kidney transplant recipients at Renji Hospital between October 2020 and August 2023. The primary outcome was a composite of a 40% decline in estimated glomerular filtration rate or end-stage kidney disease. A total of 396 patients with stable renal allograft function were included. Five machine learning methods were used to construct predictive models. Results: Among all participants, 69 (17.4%) individuals reached the outcome. The XGBoost model with the addition of SWE features achieved the highest predictive performance with 20 repeats of nested tenfold cross-validation AUC of 0.870 (95% CI: 0.862-0.878) in the training dataset and 0.868 (95% CI: 0.801-0.935) in the validation dataset. Patients with higher medullary or cortical tissue stiffness had worse prognoses. A high level (>10 kPa) of medullary SWE was an independent risk predictor (adjusted OR, 2.68; 95% CI, 1.12-6.41). Conclusion: The joint use of SWE parameters and laboratory data significantly improved the risk prediction performance for a faster decline in allograft function. This interpretable XGBoost model may provide a readily available system to guide patient monitoring using noninvasive methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.